
(2S,3S,4R)-2-Amino-1,3,4-octadecanetriol | CAS:554-62-1
(2S,3S,4R)-2-Amino-1,3,4-octadecanetriol
- 名称:糖脂; (2S,3S,4R)-2-氨基-1,3,4-十八烷三醇 | (2S,3S,4R)-2-Amino-1,3,4-octadecanetriol
- CAS号:554-62-1
- 别名:Phytosphingosine; (+)-D-ribo-Phytosphingosine; 4-D-Hydroxysphinganine; 4D-Hydroxysphinganine; C18-Phytosphingosine; D-ribo-1,3,4-Trihydroxy-2-aminooctadecane
- 分子式:C18H39NO3
- 分子量:317.51
- EINESC号:
产品描述
物理化学性质
熔点 | 102-103 ºC |
---|---|
密度 | 0.983 |
安全数据
没有数据 | 没有数据 |
---|
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Combining magnetic resonance spectroscopies, mass spectrometry, and molecular dynamics: investigation of chiral recognition by 2,6-di-O-methyl-beta-cyclodextrin.Paola Franchi et al.Journal of the American Chemical Society, 126(13), 4343-4354 (2004-04-01)
Methods for determination of all binding parameters in systems with simultaneous borate and cyclodextrin complexation.Jana Svobodová et al.Journal of chromatography. A, 1218(40), 7211-7218 (2011-08-30)
Gas phase isomeric differentiation of oleanolic and ursolic acids associated with heptakis-(2,6-di-O-methyl)-beta-cyclodextrin by electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.Zhan Yu et al.Journal of mass spectrometry : JMS, 45(4), 444-450 (2010-03-23)
Formulation and evaluation of thienorphine hydrochloride sublingual delivery system.Fei Liu et al.Chemical & pharmaceutical bulletin, 60(12), 1479-1486 (2012-12-05)
Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.Samir G Patel et al.AAPS PharmSciTech, 10(2), 660-669 (2009-05-22)
Evaluation of the separation mechanism of electrokinetic chromatography with a microemulsion and cyclodextrins using NMR and molecular modeling.Fabrizio Melani et al.Electrophoresis, 32(21), 3062-3069 (2011-10-18)
Enantiomeric separation of cis-bifenthrin by CD-MEKC: quantitative analysis in a commercial insecticide formulation.Virginia Pérez-Fernández et al.Electrophoresis, 31(9), 1533-1539 (2010-04-28)
Transport evaluation of alendronate across Caco-2 cell monolayers.F Karamustafa et al.Die Pharmazie, 64(2), 98-103 (2009-03-27)
Host-guest interaction between new nitrooxoisoaporphine and β-cyclodextrins: synthesis, electrochemical, electron spin resonance and molecular modeling studies.Fernanda Pérez-Cruz et al.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 102, 226-234 (2012-12-12)
Investigation of liposome formulation effects on rivastigmine transport through human colonic adenocarcinoma cell line (CACO-2).Z Degim et al.Die Pharmazie, 65(1), 32-40 (2010-03-02)
Grapevine cell early activation of specific responses to DIMEB, a resveratrol elicitor.Anita Zamboni et al.BMC genomics, 10, 363-363 (2009-08-08)
Morphological modification of nanostructured ultrathin-layer chromatography stationary phases.S R Jim et al.Journal of chromatography. A, 1218(40), 7203-7210 (2011-09-09)
Complexation and full characterization of the tretinoin and dimethyl-β-cyclodextrin complex.Andreia Ascenso et al.AAPS PharmSciTech, 12(2), 553-563 (2011-05-03)
Low-frequency vibrational spectrum of water around cyclodextrin and its methyl-substituted derivatives.Madhurima Jana et al.Langmuir : the ACS journal of surfaces and colloids, 26(17), 14097-14102 (2010-08-14)
Heptakis(2,6-di-O-methyl-3-O-acetyl)-beta-cyclodextrin: A water-soluble cyclodextrin derivative with low hemolytic activity.F Hirayama et al.Journal of pharmaceutical sciences, 88(10), 970-975 (1999-10-09)
Dual CD system-modified MEEKC method for the determination of clemastine and its impurities.Serena Orlandini et al.Electrophoresis, 31(19), 3296-3304 (2010-10-01)
Enantiomeric separation of some common controlled stimulants by capillary electrophoresis with contactless conductivity detection.Thitirat Mantim et al.Electrophoresis, 33(2), 388-394 (2011-12-16)
Synthesis, cytotoxicity, and phase-solubility study of cyclodextrin click clusters.Hoa Thi Le et al.Journal of pharmaceutical sciences, 103(10), 3183-3189 (2014-08-22)
Separation of stereoisomers of sertraline and its related enantiomeric impurities on a dimethylated beta-cyclodextrin stationary phase by HPLC.R Nageswara Rao et al.Journal of pharmaceutical and biomedical analysis, 50(3), 281-286 (2009-06-09)
Enantiomeric separation of amphetamine related drugs by capillary zone electrophoresis using native and derivatized beta-cyclodextrin as chiral additivesCladrowa-Runge S, et al. Journal of Chromatography A, 710(2), 339-345 (1995)
Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.Shaimaa M Badr-Eldin et al.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 70(3), 819-827 (2008-07-29)
Molecular dynamics simulations of UC781-cyclodextrins inclusion complexes in aqueous solution.Kanokthip Boonyarattanakalin et al.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 47(4), 752-758 (2012-08-28)
Molecular encapsulation of 5-nitroindazole derivatives in 2,6-dimethyl-beta-cyclodextrin: electrochemical and spectroscopic studies.Fernanda Pérez-Cruz et al.Bioorganic & medicinal chemistry, 17(13), 4604-4611 (2009-05-26)
Permeation of losartan across human respiratory epithelium: an in vitro study with Calu-3 cells.Michelle Amoako-Tuffour et al.Acta pharmaceutica (Zagreb, Croatia), 59(4), 395-405 (2009-11-19)
X-ray diffraction analysis of butyl-and isobornyl acrylate/heptakis (2, 6-di-O-methyl)-beta-cyclodextrin complexes and correlation to 1H NMR-spectraGlockner P, et al. Designed Monomers and Polymers, 5(2-3), 163-172 (2002)
DSC, X-ray and FTIR studies of a gemfibrozil/dimethyl-β-cyclodextrin inclusion complex produced by co-grinding.Z Aigner et al.Journal of pharmaceutical and biomedical analysis, 57, 62-67 (2011-09-17)
Evaluation of the cytotoxicity of beta-cyclodextrin derivatives: evidence for the role of cholesterol extraction.T Kiss et al.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 40(4), 376-380 (2010-05-04)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!